Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine is a research paper published in New England Journal of Medicine (2021). On theSindex it has a DataRank of 7.5. It has been cited 684 times, with 100 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.979
From this paper's citation signal
Citation Network Contribution
6.5
From 100 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 100 citers.
United States Government
Grant: Agreement No. W15QKN-20-9-1003
National Institute of Allergy and Infectious Diseases
Grant: UM1 AI 148372
National Institute of Allergy and Infectious Diseases
Grant: UM1 AI 148450
National Institute of Allergy and Infectious Diseases
Grant: UM1 AI 148574
National Institute of Allergy and Infectious Diseases
Grant: UM1 AI 148684
National Institute of Allergy and Infectious Diseases
Grant: UM1 AI 148684-03
National Institute of Allergy and Infectious Diseases
Grant: UM1 AI 68614HVTN
National Institute of Allergy and Infectious Diseases
Grant: UM1 AI 68618
National Institute of Allergy and Infectious Diseases
Grant: UM1 AI 68619
National Institute of Allergy and Infectious Diseases
Grant: UM1 AI 68635
National Institute of Allergy and Infectious Diseases
Grant: UM1 AI 68636
Biomedical Advanced Research and Development Authority
Grant: W15QKN-21-9-1003
NIAID NIH HHS
Grant: S10 AI174104
NIAID NIH HHS
Grant: T32 AI074492
NIAID NIH HHS
Grant: UM1 AI068619
NIAID NIH HHS
Grant: UM1 AI069470
NIAID NIH HHS
Grant: U01 AI047996
NIAID NIH HHS
Grant: UM1 AI069496
NIAID NIH HHS
Grant: UM1 AI154468
NIAID NIH HHS
Grant: U01 AI069470
NCATS NIH HHS
Grant: UL1 TR002544
NIAID NIH HHS
Grant: UM1 AI068614
NIAID NIH HHS
Grant: UM1 AI068635
NIAID NIH HHS
Grant: UM1 AI068618
NIAID NIH HHS
Grant: UM1 AI068636
FWCI
36.37
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Additional file 1 of Effectiveness and safety of SARS-CoV-2 vaccine in real-world studies: a systematic review and meta-analysis
Additional file 1 of Effectiveness and safety of SARS-CoV-2 vaccine in real-world studies: a systematic review and meta-analysis
Additional file 2 of Effectiveness and safety of SARS-CoV-2 vaccine in real-world studies: a systematic review and meta-analysis
Additional file 2 of Effectiveness and safety of SARS-CoV-2 vaccine in real-world studies: a systematic review and meta-analysis
Additional file 1 of COVID-19 vaccination efficacy in numbers including SARS-CoV-2 variants and age comparison: a meta-analysis of randomized clinical trials
Additional file 1 of COVID-19 vaccination efficacy in numbers including SARS-CoV-2 variants and age comparison: a meta-analysis of randomized clinical trials
Additional file 2 of COVID-19 vaccination efficacy in numbers including SARS-CoV-2 variants and age comparison: a meta-analysis of randomized clinical trials
Additional file 2 of COVID-19 vaccination efficacy in numbers including SARS-CoV-2 variants and age comparison: a meta-analysis of randomized clinical trials
Additional file 1 of A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies
Additional file 1 of A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies
Additional file 1 of A cross-country comparison of Covid-19 containment measures and their effects on the epidemic curves
Additional file 1 of A cross-country comparison of Covid-19 containment measures and their effects on the epidemic curves
Additional file 1 of SARS-CoV-2 vaccine breakthrough infection in the older adults: a meta-analysis and systematic review
Additional file 1 of SARS-CoV-2 vaccine breakthrough infection in the older adults: a meta-analysis and systematic review
Additional file 1 of Comparative efficacy and safety of COVID-19 vaccines in phase III trials: a network meta-analysis
Additional file 1 of Comparative efficacy and safety of COVID-19 vaccines in phase III trials: a network meta-analysis
Additional file 2 of Comparative efficacy and safety of COVID-19 vaccines in phase III trials: a network meta-analysis
Additional file 2 of Comparative efficacy and safety of COVID-19 vaccines in phase III trials: a network meta-analysis